← Back to guidelines
Dentistry4 papers

Leiomyomatous neoplasm

Last edited:

Overview

Leiomyomatous neoplasms, particularly leiomyomatous hamartomas, represent a rare group of lesions primarily affecting soft tissues, with notable occurrences in the oral cavity. These lesions are characterized by the proliferation of smooth muscle cells embedded within a fibrovascular stroma, often accompanied by other mature tissues such as fat and salivary gland elements. Despite their rarity, understanding their epidemiology, clinical presentation, diagnosis, differential diagnosis, management, and prognosis is crucial for clinicians, especially those in pediatric and dental specialties. The existing literature, though limited, provides valuable insights into the nature and management of these conditions, highlighting the importance of histopathological examination and surgical intervention.

Epidemiology

Leiomyomatous neoplasms, including hamartomas, are exceedingly rare, with the reported cases scattered across various anatomical locations, predominantly within the oral cavity. A comprehensive review encompassing thirty-nine documented cases suggests these lesions may be more prevalent than previously acknowledged, indicating a potential underreporting bias [PMID:22796195]. However, the English-language literature specifically documents only sixteen cases, underscoring their rarity and the need for continued vigilance in clinical practice [PMID:18329567]. Notably, these lesions have been observed across a wide age range, from neonates to adults, though pediatric cases, such as a 6-year-old boy with a tongue lesion, highlight their relevance in pediatric care [PMID:10530223]. Additionally, a case report detailing a 5-year-old girl with a palatal swelling further emphasizes the potential for these lesions to present in young patients [PMID:8884830]. The variability in age of onset and anatomical distribution underscores the necessity for a broad differential diagnosis in clinical settings.

Clinical Presentation

The clinical presentation of leiomyomatous neoplasms can vary significantly, often manifesting as asymptomatic masses that may be incidentally discovered. A 5-month-old male patient presented with a posterior midline tongue mass, illustrating the potential for early-onset symptoms in infants [PMID:22796195]. Interestingly, these lesions have also been reported in atypical age groups, such as a 19-year-old woman, alongside a 5-month-old boy, suggesting that age should not preclude consideration of this diagnosis [PMID:18329567]. In pediatric cases, the lesions often present as painless, localized growths. For instance, a 6-year-old boy exhibited an asymptomatic, pedunculated tubular tumor on the anterior third of the tongue, present since birth [PMID:10530223]. Similarly, a 5-year-old girl presented with a 1 cm soft, sessile swelling in the left hard palate vault, emphasizing the diverse anatomical locations where these lesions can occur [PMID:8884830]. These presentations highlight the importance of thorough clinical examination, particularly in pediatric patients, to identify and manage these rare conditions effectively.

Diagnosis

Diagnosis of leiomyomatous neoplasms relies heavily on histopathological examination and immunohistochemical analysis. Surgical excision of the lesion is often necessary not only for definitive diagnosis but also for management. Histopathological evaluation typically reveals irregularly arranged bundles of smooth muscle cells embedded within a fibrovascular stroma, sometimes admixed with mature fat and salivary tissue [PMID:10530223]. Immunohistochemistry plays a crucial role in confirming the diagnosis, with positive staining for markers such as smooth muscle actin, muscle-specific actin, S-100 protein, and desmin, which help differentiate these lesions from other soft tissue tumors [PMID:18329567]. For example, the presence of these markers in a 5-month-old patient's tongue mass confirmed the diagnosis of a leiomyomatous hamartoma [PMID:22796195]. Histopathologic differentiation from other lesions like teratomas and benign mesenchymomas is critical, often achieved through detailed microscopic examination and immunohistochemical profiling [PMID:8884830]. Clinicians should maintain a high index of suspicion and pursue comprehensive histopathological analysis to ensure accurate diagnosis.

Differential Diagnosis

Differentiating leiomyomatous hamartomas from other similar lesions can be challenging due to overlapping clinical and histopathological features. Key differential diagnoses include smooth muscle tumors (such as leiomyomas and leiomyosarcomas), teratomas, and benign mesenchymomas. Histogenesis remains a topic of debate, contributing to the complexity in distinguishing these entities [PMID:18329567]. Careful clinical evaluation, including patient history and physical examination, combined with meticulous histopathological analysis, is essential. Immunohistochemical studies, as highlighted in several case reports, are pivotal in confirming the benign nature of leiomyomatous hamartomas by identifying specific markers characteristic of smooth muscle differentiation [PMID:18329567]. For instance, the presence of smooth muscle actin and other muscle-specific markers helps rule out malignant processes and other benign mesenchymal tumors [PMID:8884830]. Clinicians must consider these nuances to avoid misdiagnosis and inappropriate management strategies.

Management

The definitive management of leiomyomatous neoplasms typically involves surgical excision. This approach not only provides a definitive diagnosis but also ensures complete removal of the lesion, thereby minimizing the risk of recurrence. Multiple case reports underscore the efficacy of surgical intervention, with no recurrence noted in follow-up periods ranging from one year post-excision [PMID:10530223] to longer durations [PMID:8884830]. For example, the excision of a leiomyomatous hamartoma from a 6-year-old boy resulted in a favorable outcome with no signs of recurrence over a one-year follow-up period [PMID:10530223]. Similarly, the surgical removal of a palatal lesion in a 5-year-old girl also demonstrated successful management without recurrence [PMID:8884830]. While surgical excision is the mainstay of treatment, the decision to proceed should be guided by the lesion's size, location, and clinical behavior. Postoperative monitoring is crucial to ensure the absence of recurrence and to address any potential complications promptly.

Prognosis & Follow-up

The prognosis for patients with leiomyomatous neoplasms, particularly hamartomas, is generally favorable following complete surgical excision. Follow-up studies indicate that recurrence is uncommon when the lesion is thoroughly removed [PMID:10530223]. Long-term outcomes reported in several case series show no recurrence during extended follow-up periods, typically ranging from one to several years post-surgery [PMID:8884830]. Regular clinical follow-up is essential to monitor for any signs of recurrence or complications, although routine imaging is not typically required unless clinically indicated. Clinicians should maintain a vigilant approach, especially in pediatric patients, to ensure sustained health and address any emerging issues promptly. The absence of recurrence in multiple reported cases underscores the effectiveness of surgical management and the benign nature of these lesions when adequately treated.

Key Recommendations

  • Clinical Awareness: Maintain a high index of suspicion for leiomyomatous neoplasms, particularly in pediatric patients presenting with oral masses.
  • Comprehensive Evaluation: Conduct thorough clinical examinations and consider imaging when necessary to assess lesion characteristics and extent.
  • Histopathological Confirmation: Advocate for surgical excision with histopathological examination, including immunohistochemical staining, to confirm the diagnosis and rule out other differential diagnoses.
  • Surgical Management: Recommend complete surgical excision as the primary treatment approach, ensuring thorough removal to prevent recurrence.
  • Post-Surgical Monitoring: Schedule regular follow-up visits to monitor for recurrence and manage any postoperative complications effectively.
  • Multidisciplinary Approach: Consider involving specialists such as pediatricians, oral surgeons, and pathologists to ensure comprehensive care and accurate diagnosis.
  • References

    1 Kuperan AB, Harirchian S, Mirani N, Quraishi HA. Case report of a congenital lingual leiomyomatous hamartoma: new epidemiologic findings and a review of the literature. International journal of pediatric otorhinolaryngology 2012. link 2 Nava-Villalba M, Ocampo-Acosta F, Seamanduras-Pacheco A, Aldape-Barrios BC. Leiomyomatous hamartoma: report of two cases and review of the literature. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2008. link 3 de la Rosa-García E, Mosqueda-Taylor A. Leiomyomatous hamartoma of the anterior tongue: report of a case and review of the literature. International journal of paediatric dentistry 1999. link 4 Napier SS, Devine JC, Rennie JS, Lamey PJ. Unusual leiomyomatous hamartoma of the hard palate: a case report. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 1996. link80357-x)

    Original source

    1. [1]
      Case report of a congenital lingual leiomyomatous hamartoma: new epidemiologic findings and a review of the literature.Kuperan AB, Harirchian S, Mirani N, Quraishi HA International journal of pediatric otorhinolaryngology (2012)
    2. [2]
      Leiomyomatous hamartoma: report of two cases and review of the literature.Nava-Villalba M, Ocampo-Acosta F, Seamanduras-Pacheco A, Aldape-Barrios BC Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics (2008)
    3. [3]
      Leiomyomatous hamartoma of the anterior tongue: report of a case and review of the literature.de la Rosa-García E, Mosqueda-Taylor A International journal of paediatric dentistry (1999)
    4. [4]
      Unusual leiomyomatous hamartoma of the hard palate: a case report.Napier SS, Devine JC, Rennie JS, Lamey PJ Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics (1996)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG